Mirae Asset Global Investments Co. Ltd. Sells 4,161 Shares of National Health Investors, Inc. (NYSE:NHI)

Mirae Asset Global Investments Co. Ltd. lessened its holdings in National Health Investors, Inc. (NYSE:NHI) by 76.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,290 shares of the real estate investment trust’s stock after selling 4,161 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in National Health Investors were worth $89,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of NHI. AlphaMark Advisors LLC bought a new position in shares of National Health Investors in the third quarter worth about $362,000. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in National Health Investors by 12.5% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 8,095 shares of the real estate investment trust’s stock worth $680,000 after purchasing an additional 902 shares during the period. Blue Trust Inc. grew its holdings in National Health Investors by 378.7% during the 3rd quarter. Blue Trust Inc. now owns 3,557 shares of the real estate investment trust’s stock valued at $299,000 after buying an additional 2,814 shares in the last quarter. Nepsis Inc. raised its position in shares of National Health Investors by 19.0% during the third quarter. Nepsis Inc. now owns 67,808 shares of the real estate investment trust’s stock valued at $5,700,000 after buying an additional 10,820 shares during the last quarter. Finally, International Assets Investment Management LLC raised its position in shares of National Health Investors by 8,399.0% during the third quarter. International Assets Investment Management LLC now owns 44,620 shares of the real estate investment trust’s stock valued at $3,751,000 after buying an additional 44,095 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Truist Financial cut their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $76.60.

National Health Investors Stock Down 0.4 %

Shares of NHI opened at $67.53 on Friday. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The stock has a market capitalization of $3.07 billion, a price-to-earnings ratio of 23.21, a price-to-earnings-growth ratio of 4.36 and a beta of 1.06. National Health Investors, Inc. has a 1 year low of $51.96 and a 1 year high of $86.13. The business’s 50 day simple moving average is $69.06 and its 200-day simple moving average is $75.30.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.